Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Remote monitoring may boost sleep apnea therapy adherence

NCT ID NCT03043716

Disease control Sponsor: ResMed Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 14, 2026 · Last updated Aug 18, 2026 · Updated 2 times

Summary

This study follows over 14,000 adults with sleep apnea who are prescribed positive airway pressure (PAP) therapy. It investigates whether using telemonitoring—where the device sends usage data to their doctor remotely—helps people use the therapy more consistently and effectively over time. Researchers will track device usage patterns and changes in sleep-related symptoms over two years to see if remote monitoring supports better long-term adherence and outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Positive airway pressure (PAP) therapy with telemonitoring
What this could lead to
If telemonitoring improves adherence, it could help more people with sleep apnea stick with PAP therapy and gain its long-term health benefits.
What could go wrong
This is an observational registry, not a controlled trial, so it can't prove cause and effect. Results may be influenced by factors like patient motivation and may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

14,147 people

The number who actually took part.

Started

Aug 2017

Finished

Jul 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult individuals with an indication for a therapy with positive airway pressure. Sleep breathing disorders can be obstructive (obstructive sleep apnea, OSA) or central (CSA) ranging from mild forms (apnoea-hypopnoea-index ˃ 5 and ˂ 15) over moderate (AHI ˃15 and ˂30) or severe (AHI ˃ 30).

Ages

18 to 99 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients older than 18 years * New indication for a prescription of a Telemonitoring (AirViewTM)-capable ResMed PAP-device * Consent to use the telemonitoring System AirViewTM (ResMed GmbH \& Co KG) * Signed Informed Consent Exclusion Criteria: \- Pregnant and breastfeeding persons

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Central sleep apnea are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

central sleep apnea syndrome obstructive sleep apnea syndrome sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Central sleep apnea Mixed sleep apnea Obstructive sleep apnea

Contacts and locations

Locations

  • Ambulante Schlafmedizin Herold/Kaa

    Fürth, Bavaria, 90762, Germany

  • Klinik für Schlafmedizin Düsseldorf Grand Arc

    Düsseldorf, North Rhine-Westphalia, 40235, Germany

  • Klinikum Nürnberg-Med Klinik 3

    Nuremberg, Bavaria, 90419, Germany

  • Ruhrlandklinik Essen

    Essen, North Rhine-Westphalia, 45239, Germany

  • Schlaf- und Beatmungszentrum Blaubeuren

    Blaubeuren Abbey, Baden-Wurttemberg, 89143, Germany

  • Zentrum für Schlafmedizin Dr. Warmuth

    Berlin, State of Berlin, 12683, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.